Liberum Capital reissued their hold rating on shares of Assura (LON:AGR) in a research report sent to investors on Friday, ThisIsMoney.Co.Uk reports.
Other equities analysts also recently issued research reports about the company. Berenberg Bank initiated coverage on Assura in a research report on Friday, November 29th. They set a hold rating and a GBX 75 ($0.98) price target on the stock. Barclays assumed coverage on Assura in a report on Tuesday, December 3rd. They issued an overweight rating and a GBX 81 ($1.06) price objective for the company. Peel Hunt restated a hold rating and issued a GBX 62 ($0.81) price objective on shares of Assura in a report on Tuesday, November 12th. Finally, Peel Hunt restated a hold rating on shares of Assura in a report on Tuesday, December 3rd. Five research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The stock presently has an average rating of Hold and a consensus target price of GBX 69.33 ($0.91).
Shares of LON AGR opened at GBX 78 ($1.02) on Friday. Assura has a twelve month low of GBX 52.50 ($0.69) and a twelve month high of GBX 77.30 ($1.01). The firm has a market cap of $1.88 billion and a PE ratio of 22.94. The business has a fifty day simple moving average of GBX 73.92 and a two-hundred day simple moving average of GBX 68.64. The company has a quick ratio of 0.76, a current ratio of 0.79 and a debt-to-equity ratio of 58.74.
The firm also recently disclosed a dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, December 12th will be issued a dividend of GBX 0.70 ($0.01) per share. This represents a yield of 0.91%. This is a positive change from Assura’s previous dividend of $0.69. The ex-dividend date is Thursday, December 12th. Assura’s dividend payout ratio (DPR) is presently 0.88%.
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high-quality patient care in the community.
See Also: Why Invest in Dividend Achievers?
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.